(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

PROCESSO PARA AUMENTAR A BIODISPONIBILIDADE DE UM AGENTE FARMACÊUTICO, FORMULAÇÃO FARMACÊUTICA PARA TRATAR UM MAMÍFERO SOFRENDO DE HIPOESTEROIDISMO, OSTEOPOROSE, ASMA, COMPOSIÇÃO DE SUBSTÂNCIA

ArquivadaInvention PatentPCT · US1995015100

Application data

Number

PI9509938

Type

Invention Patent

Filing

11/09/1995

Publication

01/27/1998

PCT

US1995015100

Progress at the INPI

  1. Filing11/09/95
  2. Publication01/27/98
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 03/27/2018. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

Amur Pharmaceuticals, Inc.

US

Amur Research Corp.

US

Supergen, Inc

US

Inventors

F. C. (pessoa física)

US

Technical data

Priority claims

US

08/348355 · 11/30/1994

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Republicação - classificação IPC

#15.11

Procedimento automático de reclassificação. As classificações IPC anteriores eram: A61K 51/00; A61K 31/595; A61K 31/56; A61K 31/01; A61K 38/28.

03/27/2018

RPI 2464

Arquivamento - Art. 36 §1° da LPI

#11.2

01/18/2005

RPI 1776

Exigência - art. 36 da LPI

#6.1

08/31/2004

RPI 1756

Transferência deferida

#25.1

Transferido de: Amur Pharmaceuticals, Inc.

06/26/2001

RPI 1590

Alteração de nome deferida

#25.4

Alterado de Amur Research Corp.

06/05/2001

RPI 1587

Notificação de entrada na fase nacional - PCT

#1.3

01/27/1998

RPI 1414

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.